Literature DB >> 11990878

The pathology of primary progressive multiple sclerosis.

W Brück1, C Lucchinetti, H Lassmann.   

Abstract

The present review will focus on the current knowledge of the pathology of primary progressive multiple sclerosis lesions. Multiple sclerosis (MS) is an inflammatory demyelinating disease with a broad clinical variability. The main disease courses are relapsing-remitting, secondary progressive and primary progressive MS. Pathological studies examining the specific underlying pathology of a defined clinical subtype are rare. Here, we focus on the pathological characteristics of the MS lesions and summarize the current findings of the pathology of primary progressive MS with respect to inflammation, oligodendrocyte myelin pathology, axon destruction and immunopathology of the lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11990878     DOI: 10.1191/1352458502ms785rr

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

1.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

2.  Discriminant analysis of the cognitive performance profile of MS patients differentiates their clinical course.

Authors:  Jürgen A Kraus; Cathleen Schütze; Barbara Brokate; Beate Kröger; Günther Schwendemann; Helmut Hildebrandt
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

3.  Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

Authors:  Sumita Adhya; Glyn Johnson; Joseph Herbert; Hina Jaggi; James S Babb; Robert I Grossman; Matilde Inglese
Journal:  Neuroimage       Date:  2006-09-22       Impact factor: 6.556

4.  Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.

Authors:  M G Marrosu; E Cocco; G Costa; M R Murru; C Mancosu; R Murru; M Lai; C Sardu; P Contu
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

Review 5.  Clinical implications of neuropathological findings in multiple sclerosis.

Authors:  Wolfgang Brück
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 6.  [Dementia as a primary symptom in late onset multiple sclerosis. Case series and review of the literature].

Authors:  T Leyhe; C Laske; G Buchkremer; H Wormstall; H Wiendl
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

7.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.

Authors:  Thomas Stahnke; Christine Stadelmann; Anne Netzler; Wolfgang Brück; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.

Authors:  Sushmita Sinha; Sandhya Subramanian; Ashley Emerson-Webber; Maren Lindner; Gregory G Burrows; Marjorie Grafe; Christopher Linington; Arthur A Vandenbark; Claude C A Bernard; Halina Offner
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-30       Impact factor: 4.147

Review 10.  Relapsing and progressive forms of multiple sclerosis: insights from pathology.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.